Term,Definition
ğŸŸ¢1,"*Level 1*, FDA-recognized biomarker predictive of response to an FDA-approved drug in this indication."
ğŸ”µ2,"*Level 2*, Standard care biomarker recommended by the NCCN or other expert panels predictive of response to an FDA-approved drug in this indication."
ğŸŸ£3A,"*Level 3A*, Compelling clinical evidence supports the biomarker as being predictive of response to a drug in this indication."
âš«ï¸4,"*Level 4*, Compelling biological evidence supports the biomarker as being predictive of response to a drug."
ğŸ”´R1,"*Level R1*, Standard care biomarker predictive of resistance to an FDA-approved drug in this indication."
ğŸ”´R2,"*Level R2*, Compelling clinical evidence supports the biomarker as being predictive of resistance to a drug."
<font color="blue">ğŸ…</font>,"Oncogenic, or likely oncogenic alteration."
MAF,"Mutation Allele Frequency (also called variant allele frequency)"
TCN,"Total Copy Number from *FACETS* algorithm"